922 results on '"Pardini, Matteo"'
Search Results
2. Diagnostic and prognostic value of dual-point amyloid PET in Alzheimer’s disease (AD) mimickers
3. Alzheimer’s disease (AD) co-pathology in dementia with Lewy bodies (DLB): implications in the disease modification era
4. Clinical validity of the Italian adaptation of the Uniform Data Set Neuropsychological Test Battery (I-UDSNB) in Mild Cognitive Impairment and Alzheimer’s Disease
5. Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease
6. Predicting disease severity in multiple sclerosis using multimodal data and machine learning
7. Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmission
8. Validation of the REM behaviour disorder phenoconversion-related pattern in an independent cohort
9. Correction: Italian adaptation of the Uniform Data Set Neuropsychological Test Battery (I‑UDSNB 1.0): development and normative data
10. Tracking the progression of Alzheimer's disease: Insights from metabolic patterns of SOMI stages
11. Different z-score cut-offs for striatal binding ratio (SBR) of DaT SPECT are needed to support the diagnosis of Parkinson’s Disease (PD) and dementia with Lewy bodies (DLB)
12. The reliability of a deep learning model in clinical out-of-distribution MRI data: a multicohort study
13. Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trial
14. Right posterior hypometabolism in Pisa syndrome of Parkinson’s disease: A key to explain body schema perception deficit?
15. A comparison of advanced semi-quantitative amyloid PET analysis methods
16. Case 3: Alzheimer’s Disease—Behavioral Variant
17. Dog-assisted physiotherapy in amyotrophic lateral sclerosis: a randomized controlled pilot study
18. Is There a Role of Vitamin D in Alzheimer’s Disease?
19. Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson’s disease (PD) do not overlap
20. Compressed sensing (CS) MP2RAGE versus standard MPRAGE: A comparison of derived brain volume measurements
21. Exploring the brain metabolic correlates of process-specific CSF biomarkers in patients with MCI due to Alzheimer's disease: preliminary data
22. Neurological long-COVID in the outpatient clinic: Two subtypes, two courses
23. Polysomnographic correlates of sleep disturbances in de novo, drug naïve Parkinson’s Disease
24. Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer’s disease
25. Is heart failure with preserved ejection fraction a ‘dementia’ of the heart?
26. The role of disconnection in explaining disability in multiple sclerosis
27. Italian adaptation of the Uniform Data Set Neuropsychological Test Battery (I-UDSNB 1.0): development and normative data
28. Estimating forest height and above-ground biomass in tropical forests using P-band TomoSAR and GEDI observations
29. Brain Metabolic Correlates of the Off-Target Effects of Enzalutamide on the Central Nervous System of Patients with Advanced Prostate Cancer
30. Selective Alteration of the Left Arcuate Fasciculus in Two Patients Affected by Creatine Transporter Deficiency
31. Cognitive impairment assessment through handwriting (COGITAT) score: a novel tool that predicts cognitive state from handwriting for forensic and clinical applications
32. Artificial intelligence of imaging and clinical neurological data for predictive, preventive and personalized (P3) medicine for Parkinson Disease: The NeuroArtP3 protocol for a multi-center research study
33. Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial
34. Age at symptom onset influences cortical thinning distribution and survival in amyotrophic lateral sclerosis
35. Cuneus/precuneus as a central hub for brain functional connectivity of mild cognitive impairment in idiopathic REM sleep behavior patients
36. Case 3: Alzheimer’s Disease—Behavioral Variant
37. The fate of patients with REM sleep behavior disorder and mild cognitive impairment
38. The use of antidepressant medications for Bipolar I and II disorders
39. Riboflavin in Neurological Diseases: A Narrative Review
40. A voxel-based lesion symptom mapping analysis of chronic pain in multiple sclerosis
41. The role of anterior prefrontal cortex in prospective memory: an exploratory FDG-PET study in early Alzheimer's disease
42. Forest 3D Radar Reflectivity Reconstruction at X-Band Using a Lidar Derived Polarimetric Coherence Tomography Basis.
43. Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to Synucleinopathy.
44. Anatomical and neurochemical bases of theory of mind in de novo Parkinson's Disease
45. Utility of quantitative EEG in early Lewy body disease
46. The Role of TNF-α in Alzheimer’s Disease: A Narrative Review
47. Predicting disease severity in multiple sclerosis using multimodal data and machine learning
48. Medical Information Extraction with NLP-Powered QABots: a Real-World Scenario
49. Tau propagation out of the MTL areas to the isocortex is facilitated by the presence of amyloid.
50. Monoaminergic Disfunctions and Misfolded Proteins levels in the Alzheimer’s Disease Continuum
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.